News

AstraZeneca CEO doubles down on U.S. amid rumors of listing shift
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly ...
AstraZeneca Books Record Quarterly Revenue as U.S, Oncology Boosts Growth
The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. U.S. revenue was up 13% ...
AstraZeneca increasing focus on US market, as it is 'first to provide access to patients': CFO
AstraZeneca CFO Aradhana Sarin tells Yahoo Finance the company sees US innovation threatened by China, even as it commits $50 billion in manufacturing.
AstraZeneca to invest $50B in US economy by 2030
British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence ...
Why AstraZeneca Stock Was Topping the Market on Tuesday
Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.
AstraZeneca's rare immune disorder drug succeeds in advanced trial
AstraZeneca said on Thursday its experimental therapy, gefurulimab, met the primary goal and all secondary endpoints in a ...
InsideNoVa on MSN8d
AstraZeneca to build its largest-ever manufacturing facility in Virginia, creating hundreds of jobs
In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...
BioSpace2d
AstraZeneca CEO Says World ‘Needs to Share’ in Global Pharma R&D
Pascal Soriot's comments came during AstraZeneca's Q2 earnings call in regard to President Donald Trump’s newly announced ...
AstraZeneca beats second-quarter profit expectations, maintains outlook
AstraZeneca beat second-quarter earnings expectations on Tuesday, helped by strong sales of key cancer, heart and kidney ...
AstraZeneca PLC (AZN) Q2 2025 Earnings Call Transcript
AstraZeneca PLC ( NASDAQ: AZN) Q2 2025 Earnings Conference Call July 29, 2025 9:00 AM ET ...